Synapse - Joachim Yahalom

Results (277)

Consolidation regimen and cerebral atrophy in patients with primary central nervous system lymphoma

Journal Article

Tringale, K. R.; Grommes, C.; Ucpinar, B. A.; Reiner, A. S.; Yahalom, J.; Cederquist, G. Y.; Schaff, L. R.; Hatzoglou, V.; Young, R. J.; Payinkay, M.; more...
International Journal of Radiation Oncology, Biology, Physics (2025)

Fulltext@MSK | Save

Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma

Journal Article

Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Severe toxicity, but long-term persistence of CAR T cells after immune checkpoint inhibitors in large B-cell lymphoma

Research Letter

Deschenes-Simard, X.; Pennisi, M.; Perales, M. A.; Shah, G. L.; Zelenetz, A. D.; Yahalom, J.; Imber, B. S.; Santomasso, B. D.; Dahi, P. B.
Leukemia and Lymphoma (2025)

Fulltext@MSK | Save

Radiation therapy in a new era of multiple myeloma management: Trends of engagement and radiologic, biochemical, and cytogenetic correlates of outcomes and response

Meeting Abstract

Dreyfuss, A.; Fregonese, B.; Usmani, S. Z.; Mailankody, S.; Imber, B. S.; Yahalom, J.
Blood (2024)

Fulltext@MSK | Save

Molecular features are associated with disease stage in diffuse large B-cell lymphoma and reveal heterogeneity in patient outcomes

Meeting Abstract

Uppal, M.; Gurumurthi, A.; Hamlin, P. A.; Falchi, L.; Horwitz, S.; Kumar, A.; Noy, A.; Lue, J. K.; Torka, P.; Arcila, M. E.; more...
Blood (2024)

Fulltext@MSK | Save

Pembrolizumab for front-line treatment of extranodal NK/T-cell lymphoma

Meeting Abstract

Moskowitz, A.; Advani, R. H.; Ganesan, N.; Chang, T.; Hancock, H.; Davey, T.; Miller, T.; Gibaldi, A.; Smith, M.; Assini, A.; more...
Blood (2024)

Fulltext@MSK | Save

Patterns of intracranial response and relapse after CNS-directed radiotherapy (CNS-RT) for patients with chemorefractory or progressive secondary CNS lymphoma (SCNSL)

Meeting Abstract

Cederquist, G.; Tringale, K.; Hajj, C.; Moore, Z.; Hubbeling, H.; Dreyfuss, A.; Fregonese, B.; Falchi, L.; Scordo, M.; Grommes, C.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas

Meeting Abstract

Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

A proof-of-principle study of split-course bridging radiotherapy (SC-BRT) prior to commercial CAR T-cell therapies for relapsed or refractory B-cell lymphomas: Results from phase 1a pilot cohort

Meeting Abstract

Imber, B. S.; Palomba, M. L.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K.; Boardman, A.; Dahi, P. B.; Lin, R. J.; Shah, G. L.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

Associations between genetic alterations in follicular lymphoma and radiosensitivity

Meeting Abstract

Wijetunga, N. A.; Lebow, E. S.; Chan, A.; Lee, J.; Fregonese, B.; Seshan, V.; Hajj, C.; Cederquist, G.; Hubbeling, H. G.; Ma, J.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save